Products Categories
CAS No.: | 62-74-8 |
---|---|
Name: | SODIUM FLUOROACETATE |
Molecular Structure: | |
|
|
Formula: | C2H3 F O2 . Na |
Molecular Weight: | 100.025 |
Synonyms: | Aceticacid, fluoro-, sodium salt (8CI,9CI);1080;Compound 1080;Fluoroacetic acidsodium salt;Fratol;Furatol;Ratbane 1080;SMFA;Sodium fluoroacetate;Sodiummonofluoroacetate;Tenate; |
EINECS: | 200-548-2 |
Melting Point: |
200-205 °C (dec.) |
Boiling Point: | 167.9°C at 760 mmHg |
Flash Point: | 55.3°C |
Solubility: | Very soluble |
Appearance: | white odourless hygroscopic powder |
Hazard Symbols: | Toxic by ingestion, inhalation, and skin absorption. TLV: 0.05 mg/m3; STEL 0.15 mg/m3. Toxic by skin absorption. For use by trained operators only, use has been restricted. |
Risk Codes: | 26/27/28-50 |
Safety: | A deadly human poison by ingestion. Experimental poison by ingestion, skin contact, intraperitoneal, subcutaneous, and intravenous routes. A very highly toxic water-soluble salt used mainly as an immediate-action rodenticide. It is absorbed rapidly by the gastrointestinal tract but slowly by the skin unless the skin is abraded or cut. It operates by blocking the Krebs cycle by formation of fluorocitric acid, which inhibits aconitase. It has an effect on either the cardiovascular or nervous system, or both, in all species and, in some species, the skeletal muscles. Humans have mixed responses, with the cardiac feature predominating. By a direct action on the heart, contractile power is lost, which leads to declining blood pressure. Ventricular premature contractions and arrhythmias are seen in all species, including humans. The central nervous system is directly attacked by sodium fluoroacetate. In humans, the action on the central nervous system produces epileptiform convulsive seizures followed by severe depression. The dangerous dose for humans is 0.5–2 mg/kg. Other species vary considerably in their response to this material, with primates and birds being the most resistant and carnivora and rodents being the most susceptible. Most domestic animals show a susceptibility falling between the two extremes indicated above. Experimental reproductive effects. When heated to decomposition it emits highly toxic fumes of Na2O and F−. |
PSA: | 40.13000 |
LogP: | -1.29420 |
Reported in EPA TSCA Inventory. EPA Extremely Hazardous Substances List.
OSHA PEL: TWA 0.05 mg/m3 (skin); STEL 0.15 mg/m3 (skin)
ACGIH TLV: TWA 0.05 mg/m3 (skin)
DFG MAK: 0.05 mg/m3
DOT Classification: 6.1; Label: Poison
The Sodium fluoroacetate, with the CAS registry number 62-74-8,is also known as Monofluoressigsaures natrium . It belongs to the product categories of Organic matters. This chemical's molecular formula is C2H2FNaO2 and Its EINECS number is 200-548-2.What's more,Its systematic name is Sodium fluoroacetate .It is a fine,white,odorless,powdered solid, which is air & water reactions water soluble. It is used as a rodenticide. It is used as kill rat poison and toxic to humans and animals.And it can be derived from hydrolysis of fluoroacetamide with sodium hydroxide .
Physical properties about Sodium fluoroacetate are:
(1)ACD/LogP: -0.226; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -3.05; (4)ACD/LogD (pH 7.4): -3.94; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Flash Point: 55.3 °C; (13)Enthalpy of Vaporization: 44.59 kJ/mol; (14)Boiling Point: 167.9 °C at 760 mmHg; (15)Vapour Pressure: 0.828 mmHg at 25°C
You can still convert the following datas into molecular structure:
(1)SMILES:[Na+].[O-]C(=O)CF;
(2)Std. InChI:InChI=1S/C2H3FO2.Na/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1;
(3)Std. InChIKey:JGFYQVQAXANWJU-UHFFFAOYSA-M;
Safety Information of Sodium fluoroacetate:
The Sodium fluoroacetate is Very toxic to aquatic organisms. So avoid release to the environment. Refer to special instructions / safety data sheets. When you use it ,keep away from food, drink and animal foodstuffs,and do not breathe dust. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) .
The toxicity data of Sodium fluoroacetate as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
bird - wild | LD50 | intraperitoneal | 102mg/kg (102mg/kg) | Australian Wildlife Research. Vol. 15, Pg. 239, 1988. | |
bird - wild | LD50 | oral | 2370ug/kg (2.37mg/kg) | Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983. | |
bird - wild | LD50 | subcutaneous | 630ug/kg (.63mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ATAXIA | Australian Wildlife Research. Vol. 11, Pg. 373, 1984. |
cat | LD50 | intraperitoneal | 300ug/kg (.3mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
cat | LD50 | oral | 350ug/kg (.35mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 37, Pg. 307, 1948. | |
chicken | LDLo | oral | 5900ug/kg (5.9mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 36, Pg. 59, 1947. | |
dog | LD50 | intravenous | 60ug/kg (.06mg/kg) | Yakkyoku. Pharmacy. Vol. 31, Pg. 1385, 1980. | |
dog | LD50 | oral | 66ug/kg (.066mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 101, Pg. 82, 1951. | |
domestic animals - goat/sheep | LD50 | intramuscular | 700ug/kg (.7mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
domestic animals - goat/sheep | LD50 | intraperitoneal | 200ug/kg (.2mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
domestic animals - goat/sheep | LD50 | oral | 500ug/kg (.5mg/kg) | CARDIAC: OTHER CHANGES | Australian Wildlife Research. Vol. 9, Pg. 487, 1982. |
domestic animals - goat/sheep | LDLo | intravenous | 519ug/kg (.519mg/kg) | ENDOCRINE: HYPERGLYCEMIA MUSCULOSKELETAL: OTHER CHANGES LIVER: OTHER CHANGES | Journal of Comparative Pathology and Therapeutics. Vol. 70, Pg. 145, 1960. |
duck | LD50 | oral | 4810ug/kg (4.81mg/kg) | Toxicology and Applied Pharmacology. Vol. 22, Pg. 556, 1972. | |
frog | LD50 | subcutaneous | 1gm/kg (1000mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
frog | LDLo | oral | 54mg/kg (54mg/kg) | Veterinary and Human Toxicology. Vol. 15, Pg. 6, 1973. | |
guinea pig | LD50 | intraperitoneal | 378ug/kg (.378mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 62, 1949. | |
guinea pig | LD50 | oral | 300ug/kg (.3mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
guinea pig | LD50 | skin | 1600ug/kg (1.6mg/kg) | CARDIAC: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 182, 1969. |
guinea pig | LD50 | subcutaneous | 250ug/kg (.25mg/kg) | Biochemical Pharmacology. Vol. 6, Pg. 169, 1961 | |
horse/donkey | LD50 | unreported | 1mg/kg (1mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
human | LDLo | oral | 714ug/kg (.714mg/kg) | "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 542, 1969. | |
mammal (species unspecified) | LD50 | intraperitoneal | 100ug/kg (.1mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 36, Pg. 59, 1947. |
mammal (species unspecified) | LD50 | oral | 110ug/kg (.11mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Australian Wildlife Research. Vol. 8, Pg. 385, 1981. |
man | LDLo | unreported | 5mg/kg (5mg/kg) | CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. |
monkey | LD50 | intravenous | 5mg/kg (5mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
monkey | LD50 | oral | 300mg/kg (300mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 182, 1969. |
mouse | LD50 | intraperitoneal | 7mg/kg (7mg/kg) | Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. Vol. 34, Pg. 193, 1979. | |
mouse | LD50 | oral | 100ug/kg (.1mg/kg) | Yakkyoku. Pharmacy. Vol. 28, Pg. 329, 1977. | |
mouse | LD50 | skin | 25300ug/kg (25.3mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 182, 1969. |
mouse | LD50 | subcutaneous | 7200ug/kg (7.2mg/kg) | National Defense Research Committee, Office of Scientific Research and Development, Progress Report.Vol. 30101, Pg. 2, 1945. | |
mouse | LD50 | unreported | 10mg/kg (10mg/kg) | Yakkyoku. Pharmacy. Vol. 30, Pg. 397, 1979. | |
pig | LD50 | intraperitoneal | 300ug/kg (.3mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
pigeon | LD50 | oral | 2mg/kg (2mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 36, Pg. 59, 1947. | |
quail | LD50 | oral | 18mg/kg (18mg/kg) | Toxicology and Applied Pharmacology. Vol. 20, Pg. 57, 1971. | |
rabbit | LD50 | intravenous | 300ug/kg (.3mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
rabbit | LD50 | oral | 340ug/kg (.34mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Australian Wildlife Research. Vol. 9, Pg. 487, 1982. |
rabbit | LD50 | subcutaneous | 281ug/kg (.281mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 62, 1949. | |
rat | LD50 | intraperitoneal | 1940ug/kg (1.94mg/kg) | British Journal of Experimental Pathology. Vol. 50, Pg. 277, 1969. | |
rat | LD50 | oral | 100ug/kg (.1mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. | |
rat | LD50 | skin | 48mg/kg (48mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 182, 1969. | |
rat | LD50 | unreported | 15mg/kg (15mg/kg) | Yakkyoku. Pharmacy. Vol. 30, Pg. 397, 1979. | |
squirrel | LD50 | intraperitoneal | 400ug/kg (.4mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 36, Pg. 59, 1947. |
squirrel | LD50 | oral | 300ug/kg (.3mg/kg) | American Journal of Public Health and the Nation's Health. Vol. 36, Pg. 1427, 1946. |